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patients aged ≥ 70 years. On multivariate analysis for cOS, no 
advantage for PMRT was detected (HR: 1.084; 95% CI:0.986-
1.191, p=0.095). Variables favouring the use of postoperative 
radiotherapy on multivariate logistic regression analysis 
included young age (p<0.001), large tumour size (pT3/4) 
(p<0.001), positive resection margin (p<0.001), and positive 
nodal status (p<0.001). High-risk patients with ≥ 4 positive 
lymph nodes who underwent mastectomy in 1998-2012 had a 
significant increased likelihood of receiving PMRT (OR 6.245) 
as compared to patients treated in the early period of 
analysis, from 1988-1997 (OR 2.837). 
 
Conclusion: The present study was useful in providing a 
window on the adoption of PMRT in a large population-based 
cohort, and to determine trends over time, as well as to 
characterize and quantify the outcome in clinical practice. A 
significant shift in indications for PMRT was registered, 
especially for high-risk patients with ≥ 4 positive lymph 
nodes. Moreover, the present findings track a substantial 
variation and apparent underuse of PMRT within the 
vulnerable population of elderly patients aged ≥ 80 years.  
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Purpose or Objective: Phase III randomised controlled trials 
and subsequent evidence-based treatment guidelines suggest 
that breast hypofractionation has low toxicity and similar 
cancer outcomes compared to patients undergoing standard 
fractionation. However, uptake of hypofractionation has not 
been universal. The aim of this study was to investigate the 
uptake of hypofractionation regimens in all public radiation 
oncology facilities in NSW.  
 
Material and Methods: Data from the NSW Clinical Cancer 
Registry were extracted, cleaned and verified. The inclusion 
criteria included those patients that are node negative breast 
cancer (TNM stage I or IIA), year of diagnosis between 2007 to 
2012, year of treatment between 2008 and 2012 and received 
external beam radiotherapy in a public radiotherapy facility. 
Data extracted included dose and fractionation type, patient 
age at first fraction, distance from treatment facility, year of 
diagnosis, year of treatment, laterality of treatment and 
department of treatment. In this analysis, standard 
fractionation was defined as dose per fraction of between 1.8 
– 2.4 Gy per fraction and hypofractionation as above 2.4 Gy 
per fraction. Univariate and multivariate analyses were 
performed to assess which factors predict for 
hypofractionation use.  
 
Results: Of the 6066 early breast cancer patients fulfilling 
the study criteria, 3947 patients (65%) had standard 
fractionation and 2119 patients (35%) received 
hypofractionation in 14 public radiotherapy centres in NSW. 
There was a wide spread of fractionation used across 
departments ranging from 6% to 92%. Hypofractionation use 
exceeded 50% in only 4 departments. Statistically significant 
factors to predict for hypofractionation use were increasing 
patient age, right sided breast cancer, further distance from 
home to the treating facility, more recent treatment, facility 
and clinician treating.  
 
Conclusion: While hypofractionation has become more 
common across NSW, there remains a substantial proportion 
of patients for whom hypofractionation would be considered 
appropriate who are not receiving hypofractionation. This has 
also been found to be the case in US studies, although we 
believe we are the first to identify laterality as an indicator. 
Understanding factors that may predict standard 
fractionation use might assist in developing strategies to 
address the issue. Hypofractionation for early breast cancer 
being adopted more widely would lead to greater patient 
convenience, better resource efficiencies in radiation 
oncology departments and perhaps even increase the use of 
post-lumpectomy radiotherapy, as some patients might 
currently forego radiotherapy due to the perceived 
inconvenience of standardly fractionated radiotherapy. 
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Purpose or Objective: To investigate inter-operator and 
inter-center variability in lymph node (LN) volume 
delineations in breast cancer (BC) nodal irradiation. 
 
Material and Methods: The study was conducted by the 
Italian Society of Radiation Oncologists (AIRO) - Breast Cancer 
Working Group. For each center, 3 radiation oncologists (ROs) 
with different expertise were involved: 1 junior (J), 1 senior 
(S) not dedicated to BC, and 1 senior (E) expert in BC. The CT 
series of 3 patients at different levels of complexity were 
selected: 1 with simple anatomy (P1), 1 obese (P2) and 1 
with impaired arm mobility (P3). ROs were asked to contour 
axillary nodes, as follows: I level (L1), II level (L2) and III 
level, the latter was further divided into infra (L3) and 
supraclavicular (L4) nodes on CT images by applying 
guidelines on breast contouring released by AIRO. The inter-
category and the inter-center variability were investigated, 
by evaluating the variability in volume size, structure overlap 
(measured as Dice similarity coefficient, DSC), and average 
Hausdorff distance (AHD) between contours. 
 
Results: Thirty-nine ROs from 14 centres participated and 
468 contours were obtained. Firstly, the analysis was focused 
on volume size. By comparing the operators, E-ROs contoured 
slightly larger volumes than S-ROs and J-ROs, with no 
statistically significant differences. Conversely, statistically 
significant differences were found in volume size when 
stratifying for patients (larger volumes were obtained for P2) 
and for LN levels (in order of size: L1, L4, L2, L3 – L1 being 
the largest and L3 the smallest). Secondly, descriptive and 
statistical intra-group analysis showed that all the 3 principal 
factors (different expertise, LN level and patient) 
contributed to inter-operator variability. When analysing 
DSC, poor agreement was found among ROs stratified for 
expertise (Fig. 1a) and the differences between S-ROs and 
the other groups were statistically significant. Considering 
the LN levels (Fig. 1b), the highest concordance was found in 
the contouring of L1 and L4 levels and the lowest for L3 
(p<0.05). Moreover, inter-operator consistency dramatically 
decreased as patient complexity increased (Fig. 1c). 
Consistent results were found in the analysis of AHD. Finally, 
considering the inter-center variability, statistically 
significant differences were found in 38.5% of comparisons 
when considering intra-center median DSC (Fig. 1d) and in 
33% of comparisons when considering intra-center median 
AHD.  
 
